You are here:

Mometasone furoate (Asmanex Twisthaler®)


Following a full submission.

Accepted for restricted use within NHS Scotland

Mometasone is the fourth inhaled steroid licensed for treatment of asthma. It is available as a dry powder inhaler. It has a similar efficacy and adverse event profile to other currently available inhaled steroids. It is suitable for use as a second line agent following treatment failure on first line inhaled steroids.

Drug Details

Drug Name: Mometasone furoate (Asmanex Twisthaler®)
SMC Drug ID: 79/03
Manufacturer: Schering-Plough Ltd
Indication: Asthma
BNF Category:
Sub Category: 3.2 Corticosteroids
Submission Type: Full submission
Status: Restricted
Date Advice Published: 10 November 2003